Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The ongoing Coronavirus (Covid-19) pandemic is causing a major global health crisis and is shaking up hospital organizations. To date, the recognized risk factors for severe forms of Covid-19 infection are elderly patients (> 70 years), obese patients, patients with chronic renal or respiratory pathologies, cardiovascular history (stroke or coronary artery disease), chronic respiratory conditions, high blood pressure, diabetes, and cancer. Covid-19 is manifested by a risk of acute respiratory distress syndrome requiring management by invasive ventilation. The lethality of this infection is around 4% in the current data.
Drastic precautionary measures for the transmission of the virus, as well as the provision of critical care beds by canceling any scheduled non-urgent intervention or consultation, have shaken up the hospital organization.
In this context, it is essential to have forward-looking data in real time to adjust the care offer and better understand the impact of Covid-19 on the patient populations treated.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Clinical consequences of a Covid-19 infection in the care population | This outcome measures the clinical consequences of a Covid-19 infection in the care population. | Year 2 |
| Measure | Description | Time Frame |
|---|---|---|
| Risk factors at M6 | This outcome evaluates the risk factors of COVID-19 at month 6 | Month 6 |
| Risk factors at year 1 | This outcome evaluates the risk factors of COVID-19. |
Not provided
Inclusion Criteria:
- Patient (of all ages) with symptoms compatible with infection by Covid-19 treated at the GHPSJ or in one of the establishments in the Paris Plaisance hospital city.
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Patientwith symptoms compatible with infection by Covid-19 treated at the GHPSJ or in one of the establishments in the Paris Plaisance hospital city.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Benoit PILMIS, MD | Fondation Hôpital Saint-Joseph | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hôpital Marie Lannelongue | Le Plessis-Robinson | 92350 | France | |||
| AURA Paris Plaisance |
Not provided
Not provided
Not provided
Not provided
| Year 1 |
| Risk factors at year 2 | This outcome evaluates the risk factors of COVID-19. | Year 2 |
| Impact of hospital reorganization on medical care at M6 | This outcome evaluates the impact of hospital reorganization on medical care at month 6. | Month 6 |
| Impact of hospital reorganization on medical care at Year 1 | This outcome evaluates the impact of hospital reorganization on medical care at year 1. | Year 1 |
| Impact of hospital reorganization on medical care at Year 2 | This outcome evaluates the impact of hospital reorganization on medical care at year 2. | Year 2 |
| Paris |
| 75014 |
| France |
| Fondation Sainte-Marie | Paris | 75014 | France |
| Groupe Hospitalier Paris Saint-Joseph | Paris | 75014 | France |
| Hôpital Bellan | Paris | 75014 | France |